Harvard Apparatus Regenerative Technology, Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $219K | ↓-15.1% | — | — | — |
| 2025-09-30 | $123K | ↑+108.5% | $-2M | ↑+8.6% | -1393.5% |
| 2025-06-30 | $317K | ↑+466.1% | $-2M | ↑+27.0% | -578.2% |
| 2025-03-31 | $45K | ↓-21.1% | $-2M | ↑+18.3% | -3711.1% |
| 2024-12-31 | $258K | ↑+309.5% | — | — | — |
| 2024-09-30 | $59K | ↑+47.5% | $-2M | ↓-15.2% | -3150.8% |
| 2024-06-30 | $56K | — | $-2M | ↑+4.4% | -4430.4% |
| 2024-03-31 | $57K | — | $-2M | ↑+29.8% | -3545.6% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 56 quarters
margin trajectory tells the operating-leverage storyGo deeper
HRGN Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyHRGN Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics